37 results
8-K
EX-10.1
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
of interest with the Company. For this purpose, a “conflict of interest” exists when a Participating Member, the parent or affiliate of a Participating Member … claims that the Company may have against the Placement Agents with respect to any conflict of interest that may arise from the fact that the views
10-Q
c34nrdg9
12 May 17
Quarterly report
12:00am
8-K
EX-10.11
wjyr4cvv
11 Feb 19
Entry into a Material Definitive Agreement
8:39am
10-12G/A
h4xoxj78n tu
18 Feb 16
Registration of securities (amended)
12:00am
10-12G
EX-3.3
7v4loo46
30 Dec 15
Registration of securities
12:00am
10-12G
EX-3.2
64hccdencu9t
12 Jan 17
Registration of securities
12:00am
10-K
fbk5mkoz7ixw4
1 Mar 18
Annual report
12:00am
8-K
EX-3.1
kj37bch0v9x82zgod5a
11 Feb 19
Entry into a Material Definitive Agreement
8:39am
10-12G/A
kunzsc 8qmortlyk
13 Mar 17
Registration of securities (amended)
12:00am
10-12G/A
jenl 331w21
6 Mar 17
Registration of securities (amended)
12:00am
10-12G
f5218 om1ne
30 Dec 15
Registration of securities
12:00am
10-12G
wqzbz7n
12 Jan 17
Registration of securities
12:00am
10-12G
EX-10.1
1cafg3455y vl
12 Jan 17
Registration of securities
12:00am
10-12G/A
EX-10.1
ije0yg jr
13 Mar 17
Registration of securities (amended)
12:00am
10-12G/A
EX-10.1
bqjhidqa
18 Feb 16
Registration of securities (amended)
12:00am